» Articles » PMID: 38706844

GRHL2 Suppression of NT5E/CD73 in Breast Cancer Cells Modulates CD73-mediated Adenosine Production and T cell Recruitment

Overview
Journal iScience
Publisher Cell Press
Date 2024 May 6
PMID 38706844
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor tissues often contain high extracellular adenosine, promoting an immunosuppressed environment linked to mesenchymal transition and immune evasion. Here, we show that loss of the epithelial transcription factor, GRHL2, triggers NT5E/CD73 ecto-enzyme expression, augmenting the conversion of AMP to adenosine. GRHL2 binds an intronic sequence and is negatively correlated with NT5E/CD73 in breast cancer cell lines and patients. Remarkably, the increased adenosine levels triggered by GRHL2 depletion in MCF-7 breast cancer cells do not suppress but mildly increase CD8 T cell recruitment, a response mimicked by a stable adenosine analog but prevented by CD73 inhibition. Indeed, NT5E expression shows a positive rather than negative association with CD8 T cell infiltration in breast cancer patients. These findings reveal a GRHL2-regulated immune modulation mechanism in breast cancers and show that extracellular adenosine, besides its established role as a suppressor of T cell-mediated cytotoxicity, is associated with enhanced T cell recruitment.

Citing Articles

Elevated GRHL2 Imparts Plasticity in ER-Positive Breast Cancer Cells.

Zheng C, Allen K, Liu T, Solodin N, Meyer M, Salem K Cancers (Basel). 2024; 16(16).

PMID: 39199676 PMC: 11353109. DOI: 10.3390/cancers16162906.


CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing.

Liao C, Engelberts P, Ioan-Facsinay A, Klip J, Schmidt T, Ruijtenbeek R Commun Biol. 2024; 7(1):983.

PMID: 39138287 PMC: 11322607. DOI: 10.1038/s42003-024-06682-9.

References
1.
Ring S, Pushkarevskaya A, Schild H, Probst H, Jendrossek V, Wirsdorfer F . Regulatory T cell-derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway. J Immunol. 2015; 194(8):3735-44. DOI: 10.4049/jimmunol.1401434. View

2.
Wang L, Fan J, Thompson L, Zhang Y, Shin T, Curiel T . CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest. 2011; 121(6):2371-82. PMC: 3104756. DOI: 10.1172/JCI45559. View

3.
Ohta A, Gorelik E, Prasad S, Ronchese F, Lukashev D, Wong M . A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A. 2006; 103(35):13132-7. PMC: 1559765. DOI: 10.1073/pnas.0605251103. View

4.
Mullins R, Pal A, Barrett T, Heft Neal M, Puram S . Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion. Cancer Res. 2022; 82(13):2329-2343. PMC: 9256788. DOI: 10.1158/0008-5472.CAN-21-4370. View

5.
Hasmim M, Xiao M, Van Moer K, Kumar A, Oniga A, Mittelbronn M . SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC. Front Immunol. 2022; 13:982821. PMC: 9501677. DOI: 10.3389/fimmu.2022.982821. View